Providence Regional Cancer Partnership — Everett, Washington

Providence Regional Cancer Partnership is a clinical research site located in Everett, Washington, United States 98201.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Providence Regional Cancer Partnership has participated in 266 clinical trials with 142 currently active.

Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma, Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor.

Sponsors: Karyopharm Therapeutics Inc, GOG Foundation, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer Partnership?

Providence Regional Cancer Partnership has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer Partnership conducted?

Providence Regional Cancer Partnership has 266 clinical trials on record, with 142 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma, Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor.

Is Providence Regional Cancer Partnership accredited by Crixeo Health?

Providence Regional Cancer Partnership has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Regional Cancer Partnership?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.